Amedisys Announces Completion of SEC Investigation

Amedisys Announces Completion of SEC Investigation

BATON ROUGE, La., July 8, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc.
(Nasdaq:AMED), one of America's leading healthcare at home companies,
announced today that it has been advised by the staff of the Securities and
Exchange Commission ("SEC") that the investigation by the SEC related to the
Company's operations and participation in the Medicare program has been
completed and that the staff does not intend to recommend any enforcement
action by the SEC. The Company had previously reported the existence of this
investigation in June 2010.

About Amedisys:

Amedisys, Inc. (Nasdaq:AMED) is a leading healthcare at home company
delivering personalized home health and hospice care to more than 360,000
patients each year. More than 2,200 hospitals and 61,900 physicians nationwide
have chosen Amedisys as a partner in post-acute care. Amedisys is focused on
delivering the care that is best for our patients, whether that is home-based
recovery and rehabilitation after an operation or injury, care focused on
empowering them to manage a chronic disease, palliative care for those with a
terminal illness, or hospice care at the end of life. Amedisys also has the
industry's first-ever nationwide Care Transitions program, designed to reduce
unnecessary hospital readmissions through patient and caregiver health
coaching and care coordination, which starts in the hospital and continues
throughout completion of the patient's home health plan of care. For more
information about the Company, please visit: http://www.amedisys.com.

We use our company website as a channel of distribution for important company
information. Important information, including press releases, analyst
presentations and financial information regarding the Company is routinely
posted on and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on our website
home page. We will also use our website to expedite public access to
time-critical information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and Exchange
Commission ("SEC") disclosing the same information. In addition, we make
available on the Investor Relations subpage of our website (under the link
"SEC filings") free of charge our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms
3, 4 and 5 and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct
and the charters for the Audit, Compensation, Nominating and Corporate
Governance, Quality of Care and Compliance and Ethics Committees of our Board
are also available on the Investor Relations subpage of our website (under the
link "Corporate Governance").

CONTACT: Amedisys, Inc.
         David Castille
         Director, Treasury/Finance
         225.299.3665
         david.castille@amedisys.com

Amedisys, Inc. logo
 
Press spacebar to pause and continue. Press esc to stop.